| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |